Please enable Javascript to get a taste of that Hopium 👼

AVIR - Company Overview - Atea Pharmaceuticals Inc
Atea Pharmaceuticals Inc
NASDAQ: avir

$7.09

USD

+$0.29

+4.27%

Prev Close

$6.80

Today's Open

$6.83

Volume

410.85K

Market Cap

589.2M

Day Range

6.80

range triangle

7.14

52W Range

6.02

range triangle

94.17

Overview

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for AVIR. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

0.312

P/E Ratio

21.79

Price to Sales

2.719

Price to Book

0.935

Profit Ratios

Profit Margin

11.90%

EBITDA Margin

18.22%

Net Profit Margin

5.11%

ROA

4.96%

Total Revenue

$207.82M

Net Profit

$10.61M

EV to EBITDA

3.577

EV to Revenue

0.652

Data source(s): Alpha Vantage